Gene Therapy for Retinal Disease: What Lies Ahead.
- Published in:
- Ophthalmologica, 2015, v. 234, n. 1, p. 1, doi. 10.1159/000438872
- By:
- Publication type:
- Article
Works matching IS 00303755 AND DT 2015 AND VI 234 AND IP 1
Results: 7
1
2
Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus.
- Published in:
- Ophthalmologica, 2015, v. 234, n. 1, p. 6, doi. 10.1159/000381357
- By:
- Publication type:
- Article
3
Front & Back Matter.
- Published in:
- Ophthalmologica, 2015, v. 234, n. 1, p. X, doi. 10.1159/000440671
- Publication type:
- Article
4
Intravitreal Ranibizumab in Daily Clinical Practice for Age-Related Macular Degeneration: Treatment of Exudative Age-Related Macular Degeneration in Real Life.
- Published in:
- Ophthalmologica, 2015, v. 234, n. 1, p. 26, doi. 10.1159/000430470
- By:
- Publication type:
- Article
5
Comparison of the Effectiveness and Prognostic Factors of Intravitreal Ranibizumab between Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy over 24 Months of Follow-Up.
- Published in:
- Ophthalmologica, 2015, v. 234, n. 1, p. 33, doi. 10.1159/000431000
- By:
- Publication type:
- Article
6
Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial.
- Published in:
- Ophthalmologica, 2015, v. 234, n. 1, p. 40, doi. 10.1159/000381865
- By:
- Publication type:
- Article
7
Subfoveal Choroidal Thickness Is Associated with Blood Hematocrit Level.
- Published in:
- Ophthalmologica, 2015, v. 234, n. 1, p. 55, doi. 10.1159/000433449
- By:
- Publication type:
- Article